Related Experiment Video
Updated: May 17, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
GCN2 has inhibitory effect on human immunodeficiency virus-1 protein synthesis and is cleaved upon viral infection
Javier del Pino1, José Luis Jiménez, Iván Ventoso
1Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain.
Abstract:
The reversible phosphorylation of the alpha-subunit of eukaryotic translation initiation factor 2 (eIF2alpha) is a well-characterized mechanism of translational control in response to a wide variety of cellular stresses, including viral infection. Beside PKR, the eIF2alpha kinase GCN2 participates in the cellular response against viral infection by RNA viruses with central nervous system tropism. PKR has also been involved in the antiviral response against HIV-1, although this antiviral effect is very limited due to the distinct mechanisms evolved by the virus to counteract PKR action. Here we report that infection of human cells with HIV-1 conveys the proteolytic cleavage of GCN2 and that purified HIV-1 and HIV-2 proteases produce direct proteolysis of GCN2 in vitro, abrogating the activation of GCN2 by HIV-1 RNA. Transfection of distinct cell lines with a plasmid encoding an HIV-1 cDNA clone competent for a single round of replication resulted in the activation of GCN2 and the subsequent eIF2alpha phosphorylation. Moreover, transfection of GCN2 knockout cells or cells with low levels of phosphorylated eIF2alpha with the same HIV-1 cDNA clone resulted in a marked increase of HIV-1 protein synthesis. Also, the over-expression of GCN2 in cells led to a diminished viral protein synthesis. These findings suggest that viral RNA produced during HIV-1 infection activates GCN2 leading to inhibition of viral RNA translation, and that HIV-1 protease cleaves GCN2 to overcome its antiviral effect.
Insights
Human immunodeficiency virus (HIV-1) infection triggers the cleavage of GCN2, an enzyme that normally inhibits viral protein synthesis. HIV-1 protease inactivates GCN2, promoting viral replication.
Area of Science:
- Molecular Biology
- Virology
- Cellular Stress Response
Background:
- Eukaryotic translation initiation factor 2 alpha (eIF2alpha) phosphorylation is a key stress response controlling protein synthesis.
- GCN2 kinase plays a role in antiviral defense against certain RNA viruses and HIV-1.
- HIV-1 has evolved mechanisms to counteract PKR, another eIF2alpha kinase involved in antiviral responses.
Purpose of the Study:
- To investigate the role of GCN2 in HIV-1 infection.
- To determine if HIV-1 proteases interact with and affect GCN2 function.
- To elucidate the mechanism by which HIV-1 evades GCN2-mediated translational control.
Main Methods:
- Infection of human cells with HIV-1 and HIV-2.
- In vitro proteolysis assays using purified HIV-1 and HIV-2 proteases with GCN2.
- Transfection of cell lines with HIV-1 cDNA clones.
- Analysis of GCN2 activation, eIF2alpha phosphorylation, and viral protein synthesis.
- Use of GCN2 knockout cells and cells with varying levels of phosphorylated eIF2alpha.
Main Results:
- HIV-1 infection leads to the proteolytic cleavage of GCN2 in human cells.
- Purified HIV-1 and HIV-2 proteases directly cleave GCN2 in vitro, inhibiting its activation by viral RNA.
- HIV-1 replication activates GCN2 and eIF2alpha phosphorylation.
- GCN2 knockout or low eIF2alpha phosphorylation conditions enhance HIV-1 protein synthesis.
- Overexpression of GCN2 reduces viral protein synthesis.
Conclusions:
- Viral RNA during HIV-1 infection activates GCN2, inhibiting viral translation.
- HIV-1 protease cleaves GCN2 to counteract this antiviral effect and promote viral replication.
- GCN2 represents a potential target for antiviral strategies against HIV-1.
More Related Videos
08:33Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Related Concept Videos
Inhibitors of Viral Protein Synthesis
GPCRs Regulate Adenylyl Cylase Activity
Two...
Leaky Scanning
Cytomegalovirus Disease
Inhibitors of Bacterial Protein Synthesis
Retroviruses